rs1049092

Positions:

• chr6-32662025-A-C
• chr6-32662025-A-G
• chr6-32662025-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2 BP4

The NM_002123.5(HLA-DQB1):​c.603T>G​(p.Asp201Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: not found (cov: 23)
• Consequence: HLA-DQB1 NM_002123.5 missense
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -1.47

Genes affected

HLA-DQB1 (HGNC:4944): (major histocompatibility complex, class II, DQ beta 1) HLA-DQB1 belongs to the HLA class II beta chain paralogs. This class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and it contains six exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]

HLA-DQB1 (HGNC:):

ACMG classification

Verdict is Uncertain_significance. Variant got 1 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (MetaRNN=0.27772415).

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
HLA-DQB1	NM_002123.5	c.603T>G	p.Asp201Glu	missense_variant	3/5	ENST00000434651.7	NP_002114.3
HLA-DQB1	NM_001243961.2	c.603T>G	p.Asp201Glu	missense_variant	3/6		NP_001230890.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
HLA-DQB1	ENST00000434651.7	c.603T>G	p.Asp201Glu	missense_variant	3/5	6	NM_002123.5	ENSP00000407332.2
HLA-DQB1	ENST00000374943.8	c.603T>G	p.Asp201Glu	missense_variant	3/6	6		ENSP00000364080.4

Frequencies

GnomAD3 genomes Cov.: 23

GnomAD4 exome Cov.: 34

GnomAD4 genome Cov.: 23

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Benign	-0.20	T
BayesDel_noAF	Benign	-0.52
CADD	Benign	1.5
DANN	Benign	0.81
DEOGEN2	Benign	0.010	T;T;T;.;.
Eigen	Benign	-1.5
Eigen_PC	Benign	-1.7
FATHMM_MKL	Benign	0.021	N
LIST_S2	Benign	0.56	T;T;T;.;T
M_CAP	Benign	0.0023	T
MetaRNN	Benign	0.28	T;T;T;T;T
MetaSVM	Benign	-0.89	T
PrimateAI	Benign	0.47	T
PROVEAN	Uncertain	-2.8	D;N;N;N;N
REVEL	Benign	0.26
Sift	Uncertain	0.028	D;T;T;T;T
Sift4G	Benign	0.59	T;T;T;T;T
Polyphen		1.0	.;D;.;D;D
Vest4		0.38
MutPred		0.65		.;Loss of phosphorylation at Y203 (P = 0.1121);Loss of phosphorylation at Y203 (P = 0.1121);Loss of phosphorylation at Y203 (P = 0.1121);Loss of phosphorylation at Y203 (P = 0.1121);
MVP		0.092
MPC		1.5
ClinPred		0.65	D
GERP RS		-9.0
gMVP		0.33

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.010		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1049092; hg19: chr6-32629802;